Bim Regulates Alloimmune-Mediated Vascular Injury Through Effects on T-Cell Activation and Death

Author:

von Rossum Anna1,Enns Winnie1,Shi Yu P.1,MacEwan Grace E.1,Malekesmaeli Mehrnoush1,Brinkman Ryan1,Choy Jonathan C.1

Affiliation:

1. From the Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada (A.v.R., W.E., Y.P.S., G.E.M., J.C.C.); and Terry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, Canada (M.M., R.B.).

Abstract

Objective— Bim is a proapoptotic Bcl-2 protein known to downregulate immune responses and to also be required for antigen-induced T-cell activation. However, it is not known how the effect of Bim on these offsetting processes determines the outcome of allogeneic immune responses. We have defined the role of Bim in regulating alloantigen-driven T-cell responses in a model of vascular rejection. Approach and Results— Bim was required for proliferation of CD4 and CD8 T cells, and for interleukin-2 production, in T cells stimulated with alloantigen in vitro. Moreover, a partial reduction in Bim expression was sufficient to attenuate T-cell activation, whereas a complete elimination of Bim was required to prevent CD4 T-cell death in response to cytokine withdrawl. When alloimmune-mediated vascular rejection was examined using an aortic interposition model, there was significantly less intimal thickening in Bim +/− , but not Bim −/− , graft recipients. T-cell proliferation in response to allograft arteries was significantly reduced in both Bim +/− and Bim −/− mice, but cell death was attenuated only in Bim −/− animals. Conclusions— Bim controls both T-cell activation and death in response to alloantigen stimulation. These processes act cooperatively to determine the outcome of immune responses in allograft arteries.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3